Barrington Research Upgrades Lifecore Biomedical to Outperform, Announces $5.5 Price Target
Benzinga Newsdesk 7 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky upgrades Lifecore Biomedical (NASDAQ:LFCR) from Market Perform to Outperform and announces $5.5 price target.
Barrington Research analyst Michael Petusky upgrades Lifecore Biomedical (NASDAQ:LFCR) from Market Perform to Outperform and announces $5.5 price target.